Assessment of a 24-hour Preoperative Course of Antibiotic Therapy for Endoscopic Urological Surgery in Case of Positive Urine Culture
NCT07206992 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 894
Last updated 2025-10-03
Summary
Endourology poses the problem of post-operative infections. The need to obtain a negative urine culture prior to surgery is accepted, and the effectiveness of this measure in reducing the risk of post-operative infection has been proven.
Current French recommendations are unanimous in favour of preventive treatment for asymptomatic bacteriuria (positive urine culture) prior to urological procedures involving contact with urine. These same recommendations specify that treatment should be brief, with a preoperative course of antibiotics lasting 48 hours.
However, the scientific literature on the subject does not provide an answer to the question of whether 48 hours is the optimal duration of preoperative antibiotic treatment to avoid the risk of postoperative infection.
In this context, it is interesting to evaluate a duration of preoperative antibiotic therapy limited to 24 hours, as no study can confirm that 24 hours of treatment is insufficient to prevent post-operative infection.
Conditions
- Urologic Surgery
Interventions
- DRUG
-
24 hours antibiotics
Antibiotic therapy will start 24 hours before urological surgery
- DRUG
-
48 hours antibiotics
Antibiotic therapy will start 48 hours before urological surgery
Sponsors & Collaborators
-
GCS Ramsay Santé pour l'Enseignement et la Recherche
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-01
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- France
Study Locations
More Related Trials
-
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
NCT03099863 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Prophylaxis for Clean Intermittent Catheterisation
NCT02145338 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
NCT01388413 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.
NCT05534399 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG
NCT05438082 ·Status: UNKNOWN ·Phase: PHASE4
-
Does Antibiotic Prophylaxis at Urinary Catheter Removal Prevent Urinary Tract Infections
NCT05577273 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter
NCT02658903 ·Status: UNKNOWN ·Phase: PHASE1
-
Ureteral Stent Exchange Abstention in Urinary Tract Infections
NCT06503588 ·Status: RECRUITING
-
Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
NCT00734968 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria
NCT07229755 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
NCT04959331 ·Status: COMPLETED ·Phase: PHASE4
-
Silver-Coated vs Standard Catheter for UTI Prevention
NCT05408533 ·Status: COMPLETED ·Phase: NA
-
Nitrofurantoin and Urinary Tract Infections (UTIs)
NCT00678041 ·Status: TERMINATED ·Phase: NA
-
Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
NCT02044965 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Infectious Complications After Cystectomy: A Prospective Observational Study
NCT05153694 ·Status: RECRUITING
-
Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections
NCT02650518 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Antibiotic Prophylaxis for Bladder Botox
NCT04444440 ·Status: RECRUITING ·Phase: PHASE4
-
Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis
NCT05761405 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prevention of Cystitis.
NCT03744338 ·Status: COMPLETED
-
the Use of Fosfomycin as a Single Dose Oral Treatment of Asymptomatic Bacteriuria
NCT03548129 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters
NCT02277171 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
NCT07239219 ·Status: RECRUITING ·Phase: NA
-
Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy
NCT00177112 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose Monurol for Treatment of Acute Cystitis
NCT00976963 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM)
NCT03868969 ·Status: UNKNOWN ·Phase: PHASE2